The FDA and the Importance of Trust

N Engl J Med. 2020 Dec 31;383(27):e148. doi: 10.1056/NEJMe2030687. Epub 2020 Sep 30.

Authors

Lindsey R Baden¹, Caren G Solomon¹, Michael F Greene¹, Ralph B D'Agostino¹, David Harrington¹

Affiliation

¹ From the Department of Obstetrics and Gynecology, Massachusetts General Hospital (M.F.G.), Boston University (R.B.D.), and the Department of Biostatistics, Harvard T.H. Chan School of Public Health, and the Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute (D.H.) - all in Boston.

PMID: 32997901
DOI: 10.1056/NEJMe2030687

No abstract available

Publication types

Editorial

MeSH terms

COVID-19 / therapy*
COVID-19 Drug Treatment
COVID-19 Serotherapy
Drug Approval
Humans
Immunization, Passive
Trust
United States
United States Food and Drug Administration*